- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05759715
Iris Color and Day-Night Changes in the Sympathovagal Ratio
March 7, 2023 updated by: Şahbender Koç, Ankara Ataturk Sanatorium Training and Research Hospital
Iris melanocytes are innervated by parasympathetic and sympathetic nerve endings.
Light affects autonomic nervous system activity via the retino-hypothalamic pathway.
The hypothesis that the day-to-night variations in the sympatovagal ratio (LF/HF) may differ among individuals with different brown iris patterns was tested.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A total of 621 healthy adults, aged between 16 and 50, with brown eyes and not diagnosed with a disease that might affect the autonomous nerve system were included in the study.
A digital camera was used to acquire iris photos.
Subjects were grouped into iris color groups (2-0 bg, 1-0 bg, 1-1 db, 1-1 lb, 2-0 b, and 1-0 b).
Iris photos were analyzed with Picture Color Analyzer RBG software.
The Central/Peripheral (R/RGB) ratio was used for objective distinction between the groups.
Using 24-h Holter ECG monitoring, the change in the sympathovagal ratio from day (between 07:00 and 23:00 hrs) to night (between 23:00 and 07:00 hrs) was determined with the formula [(Day - Night) LF/HF)/Day LF/HF].
Study Type
Observational
Enrollment (Actual)
621
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 50 years (Child, Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A total of 650 healthy individuals between the ages of 16 and 50 who applied for cardiac examination and had normal findings were recruited for the study.
Description
Inclusion Criteria:
A total of 650 healthy individuals between the ages of 16 and 50 .
Exclusion Criteria:
Diseases that could affect the autonomic nervous system; Obesity Obstructive sleep apnea syndrome Hypertension Diabetes mellitus Atrial fibrillation Coronary disease Heart failure Goiter, etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
2-0 darkbown-green (2-0 bg)
Those with distinctively dark brown in the central area, slightly green in the peripheral area,
|
Iris Color Measurement (Photos were taken of the iris with a digital camera ) LF/ HF Measurement (Using the three-channel standard ambulatory Holter recording system)
|
|
1-0 lightbrown-green (1-0 bg).
Those with slightly dark brown in the central area and green in the peripheral area,
|
Iris Color Measurement (Photos were taken of the iris with a digital camera ) LF/ HF Measurement (Using the three-channel standard ambulatory Holter recording system)
|
|
dark brown (1-1 db)
Eyes with the same color structure in the central iris and the peripheral iris.
|
Iris Color Measurement (Photos were taken of the iris with a digital camera ) LF/ HF Measurement (Using the three-channel standard ambulatory Holter recording system)
|
|
light brown (1-1 lb)
Eyes with the same color structure in the central iris and the peripheral iris.
|
Iris Color Measurement (Photos were taken of the iris with a digital camera ) LF/ HF Measurement (Using the three-channel standard ambulatory Holter recording system)
|
|
dark brown (2-0 b)
Those with distinctively dark brown in the central iris area compared to the periphery .
|
Iris Color Measurement (Photos were taken of the iris with a digital camera ) LF/ HF Measurement (Using the three-channel standard ambulatory Holter recording system)
|
|
slightly dark brown (1-0 b)
Those with slightly dark brown (1-0 b) in the central iris area compared to the periphery .
|
Iris Color Measurement (Photos were taken of the iris with a digital camera ) LF/ HF Measurement (Using the three-channel standard ambulatory Holter recording system)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
LF/HF ratio
Time Frame: one week
|
low frequency (LF, 0.04-0.15
Hz) and high frequency (HF, 0.16-0.4
Hz) measurements were taken from day and night changes in the heart rate by using the frequency-domain analysis method.
|
one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 5, 2016
Primary Completion (Actual)
May 5, 2022
Study Completion (Actual)
June 1, 2022
Study Registration Dates
First Submitted
February 27, 2023
First Submitted That Met QC Criteria
February 27, 2023
First Posted (Actual)
March 8, 2023
Study Record Updates
Last Update Posted (Estimate)
March 9, 2023
Last Update Submitted That Met QC Criteria
March 7, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1099/9.3.2016
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iris Diseases
-
Shaaban ElwanCompleted
-
Oregon Health and Science UniversityNational Eye Institute (NEI)Recruiting
-
Rabin Medical CenterCompleted
-
Cairo UniversityCompletedOther Iris and Ciliary Body DisordersSaudi Arabia
-
Prim. Prof. Dr. Oliver Findl, MBAActive, not recruitingPseudoexfoliation SyndromeAustria
-
Vance Thompson VisionNot yet recruitingPseudoexfoliation GlaucomaUnited States
-
International Maternal Pediatric Adolescent AIDS...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...CompletedHIV | IRISZimbabwe, India, South Africa, Tanzania, Uganda
-
Assiut UniversityCompleted
-
Larkin Community HospitalNova Southeastern UniversityWithdrawn
-
University of MichiganCompleted
Clinical Trials on Iris Color Measurement , LF/HF Measurement
-
CardioMEMSCompletedHeart Failure, CongestiveUnited States
-
CardioMEMSCompletedNYHA Class III Heart FailureUnited States
-
IHF GmbH - Institut für HerzinfarktforschungActive, not recruiting
-
Fondation Ophtalmologique Adolphe de RothschildCompletedRetinal Vascular Disorder | Sport InjuryFrance
-
University Hospital FreiburgCompletedCommon Variable Immunodeficiency | Non-Cirrhotic Portal HypertensionGermany
-
Fudan UniversityUnknownNasopharyngeal Carcinoma | Carotid Artery DiseasesChina
-
Norwegian University of Science and TechnologyCompletedHyperbilirubinemia, Neonatal | Jaundice, NeonatalNorway
-
University of IowaActive, not recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyCompletedDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingHeart FailureUnited Kingdom